CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ·Healthcare·Biotechnology
$0.39
-4.85%
Mkt Cap $8.01M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$12.50
Range $11.00 – $14.00
Implied Upside
+3104.3%
Consensus $12.50 vs current $0.39
NASDAQ·Healthcare·Biotechnology
$0.39
-4.85%
Mkt Cap $8.01M
No recent rating data.
Price Target (2 analysts)
$12.50
Range $11.00 – $14.00
+3104.3%
Consensus $12.50 vs current $0.39